Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)

v3.24.3
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Operating expenses:        
Research and development $ 10,808 $ 6,551 $ 23,435 $ 24,188
General and administrative 4,697 2,937 12,681 10,786
Total operating expenses 15,505 9,488 36,116 34,974
Operating loss (15,505) (9,488) (36,116) (34,974)
Other income (expense), net:        
Other income, net 713 218 4,317 630
Interest income 1,189 217 2,757 711
Interest expense (381) (980) (1,872) (2,928)
Change in fair value of derivative liability 0 0 39 0
Foreign currency transaction gain (loss), net 201 (20) 196 (21)
Other income (expense), net 1,722 (565) 5,437 (1,608)
Net loss $ (13,783) $ (10,053) $ (30,679) $ (36,582)
Net loss per share, basic $ (1.15) $ (2.27) $ (2.92) $ (8.52)
Net loss per share, diluted $ (1.15) $ (2.27) $ (2.92) $ (8.52)
Weighted average number of common shares outstanding, basic 12,014,700 4,423,617 10,490,981 4,295,178
Weighted average number of common shares outstanding, diluted 12,014,700 4,423,617 10,490,981 4,295,178
Comprehensive loss:        
Net Income (Loss) $ (13,783) $ (10,053) $ (30,679) $ (36,582)
Other comprehensive (loss) income :        
Change in unrealized (loss) gain on marketable debt securities 595 16 208 119
Total other comprehensive (loss) income 595 16 208 119
Total comprehensive loss $ (13,188) $ (10,037) $ (30,471) $ (36,463)